$XTNT Income Statement | Understand Stock

$XTNT

$0.28 -$0.01 (2.55%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Orthopedic product sales
Other revenue
Product
License
Total revenue

Cost of goods sold
Gross Profit
Operating Expenses
General and administrative
Sales and marketing
Research and development
Total Operating Expenses
Income (Loss) from Operations
Interest expense
Other (Expense) Income
Interest expense
Interest income
Unrealized foreign currency translation (loss) gain
Bargain purchase gain
Gain on divestiture
Other income (expense)
Total Other (Expense) Income
Net Income (Loss) from Operations Before Provision for Income Taxes
Provision for Income Taxes Current and Deferred
Net Income (Loss)
Net Income (Loss) Per Share:
Basic
Dilutive
Shares used in the computation:
Basic
Dilutive

Comments